125 related articles for article (PubMed ID: 6542462)
1. Beneficial effect of a thromboxane synthetase inhibitor in traumatic shock.
Hock CE; Lefer AM
Circ Shock; 1984; 14(3):159-68. PubMed ID: 6542462
[TBL] [Abstract][Full Text] [Related]
2. Protective effects of a combination thromboxane synthesis inhibitor-receptor antagonist, R-68070, during murine traumatic shock.
Aoki N; Johnson G; Siegfried MR; Lefer AM
Eicosanoids; 1989; 2(3):169-74. PubMed ID: 2534278
[TBL] [Abstract][Full Text] [Related]
3. Beneficial actions of BN 50739, a new PAF receptor antagonist, in murine traumatic shock.
Karasawa A; Rochester JA; Lefer AM
Methods Find Exp Clin Pharmacol; 1990 May; 12(4):231-7. PubMed ID: 2165204
[TBL] [Abstract][Full Text] [Related]
4. Protective effects of a new LTD4 antagonist (LY-171883) in traumatic shock.
Hock CE; Lefer AM
Circ Shock; 1985; 17(4):263-72. PubMed ID: 3841503
[TBL] [Abstract][Full Text] [Related]
5. Use of the novel cardiotonic and vasodilator agent pimobendan in traumatic shock.
Bitterman H; Smith BA; Lefer AM
Arzneimittelforschung; 1988 Oct; 38(10):1389-93. PubMed ID: 3196378
[TBL] [Abstract][Full Text] [Related]
6. Efficacy of two leukotriene antagonists in rat traumatic shock.
Levitt MA; Lefer AM
Methods Find Exp Clin Pharmacol; 1987 May; 9(5):269-73. PubMed ID: 3613754
[TBL] [Abstract][Full Text] [Related]
7. Anti-shock actions of the pyrimido-pyrimidine derivative, RA-642.
Hock CE; Lefer DJ; Lefer AM
Methods Find Exp Clin Pharmacol; 1986 May; 8(5):265-9. PubMed ID: 3724301
[TBL] [Abstract][Full Text] [Related]
8. Potentiation of the protective effects of a converting enzyme inhibitor and a thromboxane synthetase inhibitor in hemorrhagic shock.
Bitterman H; Phillips GR; Dragon G; Lefer AM
J Pharmacol Exp Ther; 1987 Jul; 242(1):8-14. PubMed ID: 3039116
[TBL] [Abstract][Full Text] [Related]
9. Protective effects of KW-3635, a novel thromboxane A2 antagonist, in murine traumatic shock.
Karasawa A; Taylor PA; Lefer AM
Eur J Pharmacol; 1990 Jun; 182(1):1-8. PubMed ID: 2401310
[TBL] [Abstract][Full Text] [Related]
10. Salutary effects of anisodamine in murine traumatic shock.
Hock CE; Su JY; Lefer AM
Circ Shock; 1983; 11(3):211-6. PubMed ID: 6652878
[TBL] [Abstract][Full Text] [Related]
11. Reduced myocardial neutrophil accumulation and infarct size following thromboxane synthetase inhibitor or receptor antagonist.
Nichols WW; Mehta J; Wargovich TJ; Franzini D; Lawson D
Angiology; 1989 Mar; 40(3):209-21. PubMed ID: 2537051
[TBL] [Abstract][Full Text] [Related]
12. Beneficial actions of antagonism of peptide leukotrienes in hemorrhagic shock.
Bitterman H; Smith BA; Lefer AM
Circ Shock; 1988 Mar; 24(3):159-68. PubMed ID: 3383353
[TBL] [Abstract][Full Text] [Related]
13. Protective actions of aprotinin in acute traumatic shock.
Araki H; Lefer AM
Arch Int Pharmacodyn Ther; 1979 Oct; 241(2):316-23. PubMed ID: 316692
[TBL] [Abstract][Full Text] [Related]
14. Efficacy of a combination thromboxane receptor antagonist and lipoxygenase inhibitor in traumatic shock.
Levitt MA; Stahl G; Lefer AM
Resuscitation; 1988 Jul; 16(3):211-20. PubMed ID: 2845544
[TBL] [Abstract][Full Text] [Related]
15. Beneficial effects of prostaglandin E1 infusion in experimental traumatic shock.
Levitt MA; Lefer AM
Crit Care Med; 1987 Aug; 15(8):769-73. PubMed ID: 3608533
[TBL] [Abstract][Full Text] [Related]
16. Protective actions of nafazatrom in traumatic shock.
Lefer AM; Messenger M
Arzneimittelforschung; 1982; 32(9):1089-91. PubMed ID: 6890831
[TBL] [Abstract][Full Text] [Related]
17. Anti-shock properties of the prostacyclin analog, iloprost, in traumatic shock.
Levitt MA; Lefer AM
Prostaglandins Leukot Med; 1986 Dec; 25(2-3):175-85. PubMed ID: 2434958
[TBL] [Abstract][Full Text] [Related]
18. Beneficial effects of U-63,557A, a thromboxane synthetase inhibitor, in an ovine model of pregnancy-induced hypertension.
Keith JC; Thatcher CD; Schaub RG
Am J Obstet Gynecol; 1987 Jul; 157(1):199-203. PubMed ID: 3605254
[TBL] [Abstract][Full Text] [Related]
19. Beneficial effects of a neutral protease inhibitor in traumatic shock.
Hock CE; Lefer AM
Pharmacol Res Commun; 1985 Mar; 17(3):217-26. PubMed ID: 4011646
[TBL] [Abstract][Full Text] [Related]
20. Prevention of endotoxin-induced pulmonary hypertension in primates by the use of a selective thromboxane synthetase inhibitor, OKY 1581.
Casey LC; Fletcher JR; Zmudka MI; Ramwell PW
J Pharmacol Exp Ther; 1982 Aug; 222(2):441-6. PubMed ID: 6896528
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
